• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偏头痛特异性生活质量问卷2.1版(MSQ v. 2.1)在接受偏头痛预防性治疗患者中的效度验证。

Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment.

作者信息

Cole Jason C, Lin Peggy, Rupnow Marcia F T

机构信息

QualityMetric, 640 George Washington Highway, Suite 201, Lincoln, RI 02865, USA.

出版信息

Qual Life Res. 2007 Sep;16(7):1231-7. doi: 10.1007/s11136-007-9217-1. Epub 2007 Apr 28.

DOI:10.1007/s11136-007-9217-1
PMID:17468941
Abstract

OBJECTIVE

Health-related quality of life (HRQoL) is an important outcome measure of migraine treatments. Although a number of migraine-specific HRQoL questionnaires exist, their measurement characteristics have only been examined for patients undergoing acute treatment of migraine. The goal of the current study was to evaluate measurement properties of the widely used Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) within a group of patients undergoing prophylactic migraine treatment.

METHODS

Various measurement properties of the MSQ were examined in a sample of 916 migraineurs undergoing prophylactic treatment who had scores at baseline and follow-up, as well as baseline SF-36. First, we used confirmatory factor analysis (CFA) and differential item functioning (DIF) to assure the accuracy and stability across groups of the MSQ scoring for all three subscales (Role Restrictive, Role Preventive, and Emotional Functioning). Next, item- and scale-level properties were examined, such as item-total correlations, internal consistency, and convergent and discriminant validity.

RESULTS

Initial findings revealed that item 12 (measuring frustration on the Emotional Functioning subscale) performed poorly. Subsequent to its removal, the 13-item MSQ displayed excellent measurement properties, including stable latent structure at baseline and endpoint, no gender or age biases on items, appropriate item-level and scale-level reliabilities, and markedly higher convergent validity compared to discriminant validity.

CONCLUSION

The 13-item MSQ appears to be an appropriate measure of migraine-specific HRQoL for patients undergoing migraine prophylaxis. Moreover, given the stability of the latent structure over time, the interpretation of scores is likely to remain quite consistent throughout a clinical trial.

摘要

目的

健康相关生活质量(HRQoL)是偏头痛治疗的一项重要结果指标。尽管存在一些针对偏头痛的HRQoL问卷,但其测量特性仅在接受偏头痛急性治疗的患者中进行过检验。本研究的目的是评估在一组接受偏头痛预防性治疗的患者中广泛使用的偏头痛特异性生活质量问卷第2.1版(MSQ v. 2.1)的测量特性。

方法

在916名接受预防性治疗的偏头痛患者样本中检验了MSQ的各种测量特性,这些患者在基线和随访时有评分,同时还有基线SF-36评分。首先,我们使用验证性因子分析(CFA)和差异项目功能(DIF)来确保MSQ所有三个子量表(角色限制、角色预防和情绪功能)评分在各组间的准确性和稳定性。接下来,检验了项目和量表层面的特性,如项目与总分的相关性、内部一致性以及收敛效度和区分效度。

结果

初步结果显示项目12(测量情绪功能子量表上的挫败感)表现不佳。去除该项目后,13项MSQ显示出优异的测量特性,包括在基线和终点时稳定的潜在结构、项目上无性别或年龄偏差、适当的项目层面和量表层面信度,以及与区分效度相比明显更高的收敛效度。

结论

13项MSQ似乎是偏头痛预防性治疗患者偏头痛特异性HRQoL的合适测量工具。此外,鉴于潜在结构随时间的稳定性,在整个临床试验中分数的解释可能会保持相当一致。

相似文献

1
Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment.偏头痛特异性生活质量问卷2.1版(MSQ v. 2.1)在接受偏头痛预防性治疗患者中的效度验证。
Qual Life Res. 2007 Sep;16(7):1231-7. doi: 10.1007/s11136-007-9217-1. Epub 2007 Apr 28.
2
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients.偏头痛特异性生活质量问卷 2.1 版(MSQ)在慢性偏头痛患者中的心理测量特性。
Qual Life Res. 2013 Jun;22(5):1123-33. doi: 10.1007/s11136-012-0230-7. Epub 2012 Jul 15.
3
Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR).希腊偏头痛特异性生活质量问卷(MSQ 版本 2.1-GR)的有效性和可靠性。
J Patient Rep Outcomes. 2024 Jul 15;8(1):72. doi: 10.1186/s41687-024-00762-4.
4
Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.识别需要改变当前急性偏头痛治疗方案的患者:当前治疗偏头痛评估(Migraine-ACT)问卷。
Curr Med Res Opin. 2004 Jul;20(7):1125-35. doi: 10.1185/030079904125004079.
5
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.验证偏头痛特异性生活质量问卷 v2.1 在发作性和慢性偏头痛中的适用性。
Headache. 2012 Mar;52(3):409-21. doi: 10.1111/j.1526-4610.2011.01997.x. Epub 2011 Sep 19.
6
MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structure.MSQ:偏头痛特异性生活质量问卷。因素结构的进一步研究。
Pharmacoeconomics. 1998 Jun;13(6):707-17. doi: 10.2165/00019053-199813060-00007.
7
The psychometric properties of the persian migraine-specific quality of life questionnaire version 2.1 in episodic and chronic migraines.波斯语偏头痛特异性生活质量问卷2.1版在发作性和慢性偏头痛中的心理测量特性。
ScientificWorldJournal. 2013 Aug 27;2013:950245. doi: 10.1155/2013/950245. eCollection 2013.
8
Validation of the Korean Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraine.验证韩文偏头痛特异性生活质量问卷 2.1 版在发作性和慢性偏头痛中的应用。
J Oral Facial Pain Headache. 2017;31(3):251-256. doi: 10.11607/ofph.1769.
9
Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.偏头痛特异性生活质量问卷 2.1 电子患者报告结局在发作性和慢性偏头痛患者中的心理测量验证和有意义的患者内变化。
Headache. 2021 Mar;61(3):511-526. doi: 10.1111/head.14031. Epub 2021 Jan 22.
10
Migraine-Specific Quality of Life Questionnaire Chinese version 2.1 (MSQv2.1-C): psychometric evaluation in patients with migraine.偏头痛特异性生活质量问卷中文修订版 2.1 版(MSQv2.1-C):偏头痛患者的心理测量评估。
Health Qual Life Outcomes. 2019 Jun 24;17(1):108. doi: 10.1186/s12955-019-1169-y.

引用本文的文献

1
Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME (US) study.使用多种进展定义的偏头痛进展发生率及危险因素:纵向OVERCOME(美国)研究结果
Headache. 2025 Apr;65(4):589-607. doi: 10.1111/head.14925. Epub 2025 Mar 14.
2
The effects of concurrent alpha-linolenic acid, L-carnitine supplementation on clinical symptoms, mental health, and quality of life in women with migraine: a randomized, triple-blind, placebo-controlled trial.同时补充α-亚麻酸和左旋肉碱对偏头痛女性临床症状、心理健康及生活质量的影响:一项随机、三盲、安慰剂对照试验
Nutr J. 2025 Mar 13;24(1):40. doi: 10.1186/s12937-025-01107-7.
3

本文引用的文献

1
Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients.系统性硬化症患者健康评估问卷残疾指数(HAQ-DI)的单因素评分验证及与早期类风湿关节炎患者的比较。
Qual Life Res. 2006 Oct;15(8):1383-94. doi: 10.1007/s11136-006-0018-8. Epub 2006 Jul 7.
2
Topiramate improves health-related quality of life when used to prevent migraine.托吡酯用于预防偏头痛时可改善健康相关生活质量。
Headache. 2005 Sep;45(8):1023-30. doi: 10.1111/j.1526-4610.2005.05183.x.
3
Development and validation of a Rasch-derived CES-D short form.
Development of the Migraine-Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study.
偏头痛相关污名化(MiRS)问卷的开发:OVERCOME(美国)研究结果
Headache. 2025 Feb;65(2):269-279. doi: 10.1111/head.14886. Epub 2025 Jan 22.
4
Factors and Reasons Associated with Hesitating to Seek Care for Migraine: Results of the OVERCOME (US) Study.与偏头痛就诊犹豫相关的因素及原因:美国OVERCOME研究结果
Neurol Ther. 2025 Feb;14(1):135-155. doi: 10.1007/s40120-024-00668-9. Epub 2024 Nov 2.
5
Evaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migraine.评价依瑞奈玛特对慢性和发作性偏头痛患者偏头痛特异性问卷的影响。
CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):1988-2000. doi: 10.1002/psp4.13048. Epub 2023 Oct 11.
6
Tai Chi for the prophylaxis of episodic migraine: protocol of a non-inferiority randomized controlled trial with mechanism exploration.太极拳预防阵发性偏头痛:一项探索机制的非劣效性随机对照试验方案。
BMC Complement Med Ther. 2023 Sep 18;23(1):328. doi: 10.1186/s12906-023-04154-x.
7
Periaqueductal gray matter echogenicity as a marker of migraine chronification: a case control study.脑桥周围灰质回声强度作为偏头痛慢性化的标志物:一项病例对照研究。
J Headache Pain. 2023 Apr 17;24(1):41. doi: 10.1186/s10194-023-01576-3.
8
Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine.用于偶发性或慢性偏头痛的工作生产力和活动障碍问卷 (WPAI) 的验证和有意义的患者内变化。
J Patient Rep Outcomes. 2023 Apr 4;7(1):34. doi: 10.1186/s41687-023-00552-4.
9
L-arginine and aged garlic extract for the prevention of migraine: a study protocol for a randomised, double-blind, placebo-controlled, phase-II trial (LARGE trial).L-精氨酸和陈年大蒜提取物预防偏头痛:一项随机、双盲、安慰剂对照、二期试验的研究方案(LARGE 试验)。
BMC Neurol. 2023 Mar 27;23(1):122. doi: 10.1186/s12883-023-03149-y.
10
Neurological Health: Not Merely the Absence of Disease: Current Wellbeing Instruments Across the Spectrum of Neurology.神经健康:不仅仅是没有疾病——神经病学领域的当前健康状况评估工具
Am J Lifestyle Med. 2022 May 5;17(2):299-316. doi: 10.1177/15598276221086584. eCollection 2023 Mar-Apr.
基于拉施模型的流调中心抑郁量表简表的编制与验证
Psychol Assess. 2004 Dec;16(4):360-72. doi: 10.1037/1040-3590.16.4.360.
4
Topiramate in migraine prevention: results of a large controlled trial.托吡酯预防偏头痛:一项大型对照试验的结果。
Arch Neurol. 2004 Apr;61(4):490-5. doi: 10.1001/archneur.61.4.490.
5
Topiramate for migraine prevention: a randomized controlled trial.托吡酯预防偏头痛:一项随机对照试验。
JAMA. 2004 Feb 25;291(8):965-73. doi: 10.1001/jama.291.8.965.
6
Using item response theory to calibrate the Headache Impact Test (HIT) to the metric of traditional headache scales.运用项目反应理论将头痛影响测试(HIT)校准至传统头痛量表的度量标准。
Qual Life Res. 2003 Dec;12(8):981-1002. doi: 10.1023/a:1026123400242.
7
Calibration of an item pool for assessing the burden of headaches: an application of item response theory to the headache impact test (HIT).用于评估头痛负担的条目池校准:项目反应理论在头痛影响测试(HIT)中的应用。
Qual Life Res. 2003 Dec;12(8):913-33. doi: 10.1023/a:1026163113446.
8
The feasibility of applying item response theory to measures of migraine impact: a re-analysis of three clinical studies.应用项目反应理论评估偏头痛影响的可行性:三项临床研究的重新分析
Qual Life Res. 2003 Dec;12(8):887-902. doi: 10.1023/a:1026175112538.
9
Epidemiology and economic impact of migraine.偏头痛的流行病学及经济影响
Curr Med Res Opin. 2001;17 Suppl 1:s4-12. doi: 10.1185/0300799039117005.
10
Pharmacologic management of acute attacks of migraine and prevention of migraine headache.偏头痛急性发作的药物治疗及偏头痛的预防
Ann Intern Med. 2002 Nov 19;137(10):840-9. doi: 10.7326/0003-4819-137-10-200211190-00014.